1. Urethrocutaneous fistulas after voluntary medical male circumcision for HIV prevention—15 African Countries, 2015–2019
- Author
-
Todd Lucas, Jonas Z. Hines, Julia Samuelson, Timothy Hargreave, Stephanie M. Davis, Ian Fellows, Amber Prainito, D. Heather Watts, Valerian Kiggundu, Anne G. Thomas, Onkemetse Conrad Ntsuape, Kunle Dare, Elijah Odoyo-June, Leonard Soo, Likabelo Toti-Mokoteli, Robert Manda, Martin Kapito, Wezi Msungama, James Odek, Jotamo Come, Marcos Canda, Nuno Gaspar, Aupokolo Mekondjo, Brigitte Zemburuka, Collen Bonnecwe, Peter Vranken, Susan Mmbando, Daimon Simbeye, Fredrick Rwegerera, Nafuna Wamai, Shelia Kyobutungi, James Exnobert Zulu, Omega Chituwo, Sinokuthemba Xaba, John Mandisarisa, and Carlos Toledo
- Subjects
Male circumcision ,Intraoperative complications ,HIV ,Fistula ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Background Voluntary medical male circumcision (VMMC) is an HIV prevention strategy recommended to partially protect men from heterosexually acquired HIV. From 2015 to 2019, the President’s Emergency Plan for AIDS Relief (PEPFAR) has supported approximately 14.9 million VMMCs in 15 African countries. Urethrocutaneous fistulas, abnormal openings between the urethra and penile skin through which urine can escape, are rare, severe adverse events (AEs) that can occur with VMMC. This analysis describes fistula cases, identifies possible risks and mechanisms of injury, and offers mitigation actions. Methods Demographic and clinical program data were reviewed from all reported fistula cases during 2015 to 2019, descriptive analyses were performed, and an odds ratio was calculated by patient age group. Results In total, 41 fistula cases were reported. Median patient age for fistula cases was 11 years and 40/41 (98%) occurred in patients aged
- Published
- 2021
- Full Text
- View/download PDF